Literature DB >> 19103859

An audit of immunisation status of sickle cell patients in Coventry, UK.

M Howard-Jones1, L Randall, B Bailey-Squire, J Clayton, N Jackson.   

Abstract

Protection against infection is a key aim of any care programme for patients with sickle cell disorders, and is one of the stated objectives of the UK national neonatal screening programme. An audit of the immunisation status of the 58 sickle cell patients living in Coventry was carried out against UK national guidance (2006). Among 25 children (aged < or =16 years), 14 (56%) had complete immunisation against pneumococcus, Haemophilus influenzae type b (Hib) and meningococcus group C (MenC), with eight (32%) having some coverage, and three (12%) having none at all. Among 33 adults, only four patients (12%) had complete coverage, with up-to-date coverage against pneumococcus 21%, Hib 18% and MenC 15%. Current (ie, within the last year) immunisation against viral influenza was found in only 12% of adults and 8% of children. These rates are similar to those found in other UK studies. If the potential benefits of neonatal screening are to be realised, an effective immunisation programme is essential. There are key roles for haemoglobinopathy nurse specialists, and the proposed national haemoglobinopathy database, in improving the rates of immunisation coverage.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19103859     DOI: 10.1136/jcp.2008.058982

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  10 in total

1.  Impact of a Clinical Pharmacy Service on the Management of Patients in a Sickle Cell Disease Outpatient Center.

Authors:  Jin Han; Shubha Bhat; Michel Gowhari; Victor R Gordeuk; Santosh L Saraf
Journal:  Pharmacotherapy       Date:  2016-10-03       Impact factor: 4.705

2.  Severe pandemic H1N1 and seasonal influenza in children and young adults with sickle cell disease.

Authors:  John J Strouse; Megan E Reller; David G Bundy; Martha Amoako; Maria Cancio; Rachel N Han; Alexandra Valsamakis; James F Casella
Journal:  Blood       Date:  2010-07-23       Impact factor: 22.113

3.  Improvement in influenza vaccination rates in a pediatric sickle cell disease clinic.

Authors:  Amy E Sobota; Patricia L Kavanagh; William G Adams; Elizabeth McClure; Delmaude Farrell; Philippa G Sprinz
Journal:  Pediatr Blood Cancer       Date:  2014-12-24       Impact factor: 3.167

4.  Ambulatory quality indicators to prevent infection in sickle cell disease.

Authors:  Lauren M Beverung; David Brousseau; Raymond G Hoffmann; Ke Yan; Julie A Panepinto
Journal:  Am J Hematol       Date:  2014-03       Impact factor: 10.047

5.  Maintenance of a High Influenza Vaccination Rate and Improvement in Health Outcomes in a Pediatric Sickle Cell Disease Clinic.

Authors:  Zachary C Lo; Amy E Sobota
Journal:  J Pediatr Hematol Oncol       Date:  2022-01-01       Impact factor: 1.170

6.  Significance of electronic health records: A comparative study of vaccination rates in patients with sickle cell disease.

Authors:  Asli Korur; Süheyl Asma; Cigdem Gereklioglu; Soner Solmaz; Can Boga; Akatlı Kürsat Ozsahin; Altug Kut
Journal:  Pak J Med Sci       Date:  2017 May-Jun       Impact factor: 1.088

7.  Vascular Permeability Drives Susceptibility to Influenza Infection in a Murine Model of Sickle Cell Disease.

Authors:  Erik A Karlsson; Thomas H Oguin; Victoria Meliopoulos; Amy Iverson; Alexandria Broadnax; Sun-Woo Yoon; Tamara Pestina; Paul Thomas; Richard Webby; Stacey Schultz-Cherry; Jason W Rosch
Journal:  Sci Rep       Date:  2017-03-03       Impact factor: 4.379

8.  Evaluation of newborn sickle cell screening programme in England: 2010-2016.

Authors:  Allison Streetly; Rupa Sisodia; Moira Dick; Radoslav Latinovic; Kirsty Hounsell; Elizabeth Dormandy
Journal:  Arch Dis Child       Date:  2017-11-05       Impact factor: 3.791

9.  Air Drep-A Retrospective Study Evaluating the Influence of Weather Conditions and Viral Epidemics on Vaso-Occlusive Crises in Patients with Sickle Cell Disease Living in French Guiana.

Authors:  Marie-Claire Parriault; Claire Cropet; Aniza Fahrasmane; Stéphanie Rogier; Michaël Parisot; Mathieu Nacher; Narcisse Elenga
Journal:  Int J Environ Res Public Health       Date:  2019-07-31       Impact factor: 3.390

Review 10.  Gaps in knowledge about the vaccine coverage of immunocompromised children: a scoping review.

Authors:  Shannon E MacDonald; Airlie Palichuk; Linda Slater; Hailey Tripp; Laura Reifferscheid; Catherine Burton
Journal:  Hum Vaccin Immunother       Date:  2021-07-16       Impact factor: 3.452

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.